Lindbrook Capital, LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 82 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2023$1,433
-0.6%
380.0%0.00%
Q2 2023$1,441
-47.6%
38
-66.4%
0.00%
Q1 2023$2,748
-61.1%
113
-53.5%
0.00%
-100.0%
Q4 2022$7,057
+41.1%
243
+34.3%
0.00%0.0%
Q3 2022$5,000
+150.0%
181
+182.8%
0.00%
Q2 2022$2,0000.0%64
+45.5%
0.00%
Q1 2022$2,000
-92.0%
44
-91.3%
0.00%
-100.0%
Q4 2021$25,000
-37.5%
506
-19.4%
0.00%
-60.0%
Q3 2021$40,000
-14.9%
628
-3.1%
0.01%
-9.1%
Q2 2021$47,0000.0%648
+0.8%
0.01%0.0%
Q1 2021$47,0000.0%6430.0%0.01%0.0%
Q4 2020$47,000
+571.4%
643
+431.4%
0.01%
+450.0%
Q3 2020$7,000
-36.4%
121
-26.2%
0.00%
-33.3%
Q2 2020$11,000
-42.1%
164
-46.9%
0.00%
-57.1%
Q1 2020$19,000
+850.0%
309
+1445.0%
0.01%
+600.0%
Q4 2019$2,0000.0%200.0%0.00%0.0%
Q3 2019$2,000200.00%
Q4 2018$000.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q3 2023
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 565,951$24,483,0008.44%
Murchinson Ltd. 162,703$7,039,0001.34%
Eversept Partners, LP 220,286$9,529,5720.73%
BRANDES INVESTMENT PARTNERS, LP 379,322$16,410,0000.35%
Analyst IMS Investment Management Services Ltd. 17,657$764,0000.07%
Claret Asset Management Corp 7,279$315,0000.06%
ACADIAN ASSET MANAGEMENT LLC 326,427$14,086,0000.06%
Renaissance Technologies 678,300$29,343,0000.03%
HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC 191,820$8,298,0000.03%
ARK Investment Management 55,566$2,404,0000.01%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders